Scandinavian ChemoTech (Sweden) Probability of Future Stock Price Finishing Under 2.35
| CMOTEC-B | SEK 1.74 0.04 2.35% |
Scandinavian |
Scandinavian ChemoTech Target Price Odds to finish below 2.35
The tendency of Scandinavian Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to stay under kr 2.35 after 90 days |
| 1.74 | 90 days | 2.35 | about 98.0 |
Based on a normal probability distribution, the odds of Scandinavian ChemoTech to stay under kr 2.35 after 90 days from now is about 98.0 (This Scandinavian ChemoTech AB probability density function shows the probability of Scandinavian Stock to fall within a particular range of prices over 90 days) . Probability of Scandinavian ChemoTech price to stay between its current price of kr 1.74 and kr 2.35 at the end of the 90-day period is about 86.42 .
Assuming the 90 days trading horizon Scandinavian ChemoTech has a beta of 0.62 suggesting as returns on the market go up, Scandinavian ChemoTech average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Scandinavian ChemoTech AB will be expected to be much smaller as well. Additionally Scandinavian ChemoTech AB has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Scandinavian ChemoTech Price Density |
| Price |
Predictive Modules for Scandinavian ChemoTech
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Scandinavian ChemoTech. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Scandinavian ChemoTech's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Scandinavian ChemoTech Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Scandinavian ChemoTech is not an exception. The market had few large corrections towards the Scandinavian ChemoTech's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Scandinavian ChemoTech AB, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Scandinavian ChemoTech within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.19 | |
β | Beta against Dow Jones | 0.62 | |
σ | Overall volatility | 0.19 | |
Ir | Information ratio | -0.06 |
Scandinavian ChemoTech Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Scandinavian ChemoTech for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Scandinavian ChemoTech can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Scandinavian ChemoTech generated a negative expected return over the last 90 days | |
| Scandinavian ChemoTech may become a speculative penny stock | |
| Scandinavian ChemoTech has high historical volatility and very poor performance | |
| Scandinavian ChemoTech has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 49 K. Net Loss for the year was (17.74 M) with profit before overhead, payroll, taxes, and interest of 2.86 M. | |
| Scandinavian ChemoTech AB has accumulated about 5.62 M in cash with (19.18 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.65. | |
| Roughly 26.0% of the company shares are held by company insiders |
Scandinavian ChemoTech Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Scandinavian Stock often depends not only on the future outlook of the current and potential Scandinavian ChemoTech's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Scandinavian ChemoTech's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 9.6 M | |
| Cash And Short Term Investments | 8.7 M |
Scandinavian ChemoTech Technical Analysis
Scandinavian ChemoTech's future price can be derived by breaking down and analyzing its technical indicators over time. Scandinavian Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Scandinavian ChemoTech AB. In general, you should focus on analyzing Scandinavian Stock price patterns and their correlations with different microeconomic environments and drivers.
Scandinavian ChemoTech Predictive Forecast Models
Scandinavian ChemoTech's time-series forecasting models is one of many Scandinavian ChemoTech's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Scandinavian ChemoTech's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Scandinavian ChemoTech
Checking the ongoing alerts about Scandinavian ChemoTech for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Scandinavian ChemoTech help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Scandinavian ChemoTech generated a negative expected return over the last 90 days | |
| Scandinavian ChemoTech may become a speculative penny stock | |
| Scandinavian ChemoTech has high historical volatility and very poor performance | |
| Scandinavian ChemoTech has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 49 K. Net Loss for the year was (17.74 M) with profit before overhead, payroll, taxes, and interest of 2.86 M. | |
| Scandinavian ChemoTech AB has accumulated about 5.62 M in cash with (19.18 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.65. | |
| Roughly 26.0% of the company shares are held by company insiders |
Other Information on Investing in Scandinavian Stock
Scandinavian ChemoTech financial ratios help investors to determine whether Scandinavian Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Scandinavian with respect to the benefits of owning Scandinavian ChemoTech security.